DWTX Stock Summary and Trading Ideas (Dogwood Therapeutics | NASDAQ:DWTX)

Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its product candidates include IMC-1 and IMC-2. IMC-1 is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.

Dogwood Therapeutics trades on the NASDAQ stock market under the symbol DWTX.

As of March 24, 2026, DWTX stock price declined to $2.59 with 79,507 million shares trading.

DWTX has a beta of 0.39, meaning it tends to be less sensitive to market movements. DWTX has a correlation of 0.00 to the broad based SPY ETF.

DWTX has a market cap of $86.24 million. This is considered a Micro Cap stock.

The top ETF exchange traded funds that DWTX belongs to (by Net Assets): VXF.

DWTX has underperformed the market in the last year with a price return of -59.1% while the SPY ETF gained +17.1%. DWTX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -33.2% and -15.4%, respectively, while the SPY returned -4.8% and -3.4%, respectively.

DWTX support price is $2.58 and resistance is $2.98 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DWTX shares will trade within this expected range on the day.